---
title: "Archimed completes take-private of Esperion in deal valued up to $1.1 billion"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292496629.md"
description: "Archimed completed the take-private acquisition of Esperion on July 13, 2026, in a deal valued up to $1.1 billion. Esperion shareholders received $3.16 per share in cash, representing a 58% premium, plus rights to contingent milestone payments up to $100 million based on future net sales. Following the closing, Esperion shares were delisted from Nasdaq."
datetime: "2026-07-13T13:32:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292496629.md)
  - [en](https://longbridge.com/en/news/292496629.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292496629.md)
generator: "portal-rs"
---

# Archimed completes take-private of Esperion in deal valued up to $1.1 billion

-   ARCHIMED completed its acquisition of Esperion on July 13, 2026, valuing the deal at up to USD 1.1 billion on a fully diluted basis. \* Esperion shareholders received USD 3.16 per share in cash, a 58% premium to the April 30, 2026 close. \* Holders also received rights to contingent milestone payments totaling up to USD 100 million tied to future net sales performance. \* Esperion shares stopped trading and were delisted from Nasdaq following the closing. \* The acquisition was made through ARCHIMED’s MED Platform II fund, with unitranche debt provided by Pharmakon Advisors. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Archimed SAS published the original content used to generate this news brief on July 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ESPR.US](https://longbridge.com/en/quote/ESPR.US.md)

## Related News & Research

- [Esperion acquired in cash-and-CVR merger transaction](https://longbridge.com/en/news/292521304.md)
- [Top Esperion Executives Quietly Unload a Wave of Shares](https://longbridge.com/en/news/290261607.md)
- [ES Group to present January–June interim report in webcast and conference call](https://longbridge.com/en/news/296326732.md)
- [Simpar sells 50% stake in BRT Sorocaba concession to Mobibrasil Sorocaba](https://longbridge.com/en/news/296656506.md)
- [Alliança Saúde names Grant Thornton as independent auditor, replacing BKR Lopes Machado](https://longbridge.com/en/news/296278375.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**